Health
Revolution Medicines' Pancreatic Cancer Drug Under Scrutiny
Revolution Medicines' pancreatic cancer drug, which has not yet been approved, is generating renewed interest. Discussions are now focusing on potential expanded uses and approval timelines.
Coverage timeline — 1 article
STAT News
Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
2026-06-04 10:30 UTC